‘Dental Imaging Market Over $1.9 Billion In 2017’ Says Visiongain Report

29 August 2017
Pharma

Visiongain’s new report the Dental Imaging Technology Market Forecasts 2017-2027: Analysis by Medical Application (Diagnostic, Forensic, Cosmetic), Current and Future Technologies (X-ray, CBCT, Intraoral Camera) and End User (Hospitals and Clinics, Academia and Research Institutes) indicates that the global dental imaging market will see over $1.9bn in revenue in 2017.

The lead analyst of the report said:

“In the past three decades, dentistry has witnessed tremendous advances across all of its branches. With these advances, the need for more precise diagnostic tools, especially imaging methods, have become increasingly vital. From the simple intra-oral periapical X-rays, advanced imaging techniques like computed tomography (CT), cone beam computed tomography (CBCT), magnetic resonance imaging (MRI) and ultrasound have also found their place in modern dentistry. The change from analogue to digital radiography has not only made the process simpler and faster, but has also made image storage, manipulation (brightness/contrast, image cropping, etc.) and retrieval easier. Three-dimensional (3-D) imaging has made the complex cranio-facial structures more accessible for examination and also helped in early and accurate diagnosis of deep seated lesions.
The global dental imaging technologies market is expected to witness considerable growth over the forecast period. The main drivers for the growth include technological advances such as 3-D imaging; increasing ageing populations leading to growth in oral diseases; rising oral care awareness and increasing disposable income in emerging economies; growth in cosmetic dentistry; and a shift towards digital dental imaging systems.”

The 152 page report contains 120 tables, charts and graphs that add visual analysis in order to explain developing trends within the dental imaging market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading dental imaging technology submarkets, namely X-ray systems (both intraoral and extraoral), Cone beam computed tomography (CBCT) and intraoral cameras (IOCs). The report also includes forecasts for the applications of dental imaging, including diagnostic and therapeutic use, cosmetic use and forensic use. In addition the report also contains forecasts for the dental imaging market by end-user, including hospitals and clinics, forensic institutes, academia and research institutes.

The 152 page report offers market forecasts and analysis for 4 leading regional and 10 national markets, as well as the rest of the world, rest of Europe and rest of Asia markets. In addition, the report contains a dedicated leading companies’ chapter covering more than 8 companies leading the field in dental imaging technology.

The Dental Imaging Technology Market Forecasts 2017-2027: Analysis by Medical Application (Diagnostic, Forensic, Cosmetic), Current and Future Technologies (X-ray, CBCT, Intraoral Camera) and End User (Hospitals and Clinics, Academia and Research Institutes) report will be of value to anyone who wants to better understand the dental imaging market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the dental imaging industry.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever